| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 192.670 | 197.517 | 187.580 | 184.109 | 162.097 | 186.506 | 185.719 | 222.439 | 248.182 | 268.989 |
| Total Income - EUR | 196.570 | 197.366 | 187.593 | 184.273 | 162.760 | 186.504 | 185.723 | 222.443 | 248.176 | 268.996 |
| Total Expenses - EUR | 181.052 | 180.617 | 181.296 | 176.523 | 157.715 | 183.966 | 176.373 | 211.453 | 233.442 | 255.993 |
| Gross Profit/Loss - EUR | 15.518 | 16.748 | 6.297 | 7.750 | 5.045 | 2.539 | 9.351 | 10.990 | 14.734 | 13.003 |
| Net Profit/Loss - EUR | 13.030 | 14.022 | 4.170 | 5.890 | 3.351 | 1.103 | 7.490 | 8.697 | 12.107 | 10.923 |
| Employees | 4 | 4 | 4 | 5 | 4 | 4 | 6 | 5 | 5 | 5 |
Check the financial reports for the company - Miss B Pharm Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 1.848 | 1.606 | 1.142 | 1.539 | 1.548 | 1.455 | 817 | 1.318 | 1.237 | 853 |
| Current Assets | 41.529 | 47.360 | 33.464 | 37.394 | 34.476 | 29.810 | 34.972 | 42.159 | 60.666 | 67.945 |
| Inventories | 22.523 | 25.428 | 16.231 | 10.124 | 14.312 | 9.236 | 15.542 | 21.483 | 33.563 | 34.597 |
| Receivables | 14.352 | 10.966 | 13.561 | 22.248 | 14.470 | 15.342 | 16.424 | 18.028 | 19.528 | 26.015 |
| Cash | 4.654 | 10.966 | 3.673 | 5.023 | 5.694 | 5.231 | 3.006 | 2.649 | 7.575 | 7.333 |
| Shareholders Funds | 30.643 | 12.755 | 4.223 | 10.132 | 13.193 | 14.132 | 21.309 | 27.510 | 39.534 | 34.940 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 13.024 | 36.228 | 30.383 | 28.801 | 22.831 | 17.132 | 14.481 | 15.967 | 22.369 | 33.859 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Miss B Pharm Srl